iBio, Inc. IBIO
NASDAQ IBIO
$0.77 -0.07 (-8.68%)
As of: Oct 22, 2026 · 12:41 PM EDT

iBio (IBIO) Other Non-Current Liabilities (2022 - 2023)

Updated

iBio (IBIO) reported Other Non-Current Liabilities of $263,000 for fiscal Q1 2024 (quarter ended Sep 30, 2023), down 50.1% from the prior quarter.

Analysis

iBio (IBIO) Other Non-Current Liabilities (2022 - 2023) Analysis & Trends

At the end of FY2023 (ended Jun 30, 2023), iBio posted Other Non-Current Liabilities of $527,000.

  • Per Business Quant data, the three fiscal quarters before Q1 2024 came in at $527,000 (Q4 2023), $791,000 (Q3 2023) and $1.07 million (Q2 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,168.95 Bn 1,137.53 Bn 19.71 Bn
2 Johnson & Johnson 642.08 Bn 560.60 Bn 17.26 Bn
3 AbbVie 500.03 Bn 473.14 Bn 12.70 Bn
4 Merck 359.04 Bn 313.42 Bn 12.21 Bn
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn
6 Astrazeneca 267.05 Bn 240.74 Bn 12.86 Bn
7 Amgen 241.60 Bn 197.00 Bn 7.24 Bn
8 Gilead Sciences 192.44 Bn 166.64 Bn 6.22 Bn
9 Pfizer 171.37 Bn 118.01 Bn 10.94 Bn
10 iBio 79.16 Mn -186.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 263,000.00
Jun 30, 2023 527,000.00
Mar 31, 2023 791,000.00
Dec 31, 2022 1.07 Mn
API Access

iBio Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=IBIO&period=max&api_key=YOUR_API_KEY